Strategic report Corporate governance Financial statements Financial statements Notes to the consolidated financial statements continued 19.
Trade and other receivables continued As at 31 December Past due 2016 2015 Not past due $m $m on the less than 90 between 91 between 181 reporting date days and 180 days and 360 days Over one year Impaired Total Finished goods 120 55 At 31 December 2015 $m $m $m $m $m $m $m Work-in-progress 73 33 Total trade receivables as Raw and packing materials 229 144 at 31 December 2015 423 50 25 15 4 43 560 Goods in transit 18 11 Related allowance for Spare parts 19 8 doubtful debts 43 43 459 251 423 50 25 15 4 517 Chargebacks and other Inventories are stated net of provision as follows: allowances 85 ` As at 31 As at 31 Net receivables 432 December Translation December 2015 Additions Utilisation adjustments 2016 The Group establishes an allowance for impairment that represents its estimate of losses in respect of specific trade and other receivables, $m $m $m $m $m where it is deemed that a receivable may not be recoverable.
When the receivable is deemed irrecoverable, the allowance account is Provisions against inventory 47 70 50 2 65 written-off against the underlying receivable.
More details on the Groups policy for credit and concentration risk are provided in Note 30.
Trade and other receivables As at 31 December 2016 2015 21.
Collateralised and restricted cash $m $m Collateralised and restricted cash amounted to $7 million mainly represent restricted cash held in an escrow account of $2 million 2015: Trade receivables 699 432 $38 million related to the acquisition of EIMC United Pharmaceuticals note 43, and restricted cash retained against short-term bank Prepayments 44 39 transactions granted to the Groups Sudanese, Algerian and US operations of $5 million 2015: Sudanese, Algerian, Jordanian and US VAT and sales tax recoverable 14 15 operations of $2 million.
Cash and cash equivalents Trade receivables are stated net of provisions for chargebacks and doubtful debts as follows: As at 31 December As at 31 As at 31 2016 2015 December Translation Acquisition of December $m $m 2015 Additions Utilisation adjustments subsidiaries 2016 Cash at banks and on hand 77 102 $m $m $m $m $m $m Chargebacks and other allowances 85 1,575 1,563 164 261 Time deposits 68 429 Money market deposits 10 22 Doubtful debts 43 12 1 54 155 553 128 1,587 1,563 1 164 315 Cash and cash equivalents include highly liquid investments with maturities of three months or less.
The following table provides a summary of the age of trade receivables: Past due Not past due 23.
Other current assets on the less than 90 between 91 between 181 As at 31 reporting date days and 180 days and 360 days Over one year Impaired Total December At 31 December 2016 $m $m $m $m $m $m $m 2016 2015 Total trade receivables as $m $m 841 70 13 24 12 54 1,014 at 31 December 2016 Price adjustment receivable note 43 34 Related allowance for Investment designated at fair value 20 20 doubtful debts 54 54 Others 12 5 841 70 13 24 12 960 66 25 Chargebacks and other allowances 261 Price adjustment receivable represents the current portion of the total contingent receivable of $118 million in relation of West-Ward Net receivables 699 Columbus acquisition note 30, and 43.
During the year, the Group received $82 million in cash as part of certain working capital, milestones and other receivables.
Investment designated at fair value: represents the agreement the Group entered in 2015 with an asset management firm to manage a $20 million portfolio of underlying debt instruments.
The asset is measured at fair value and classed as level 1 as it uses quoted prices in active markets.
Annual Report 2016 179 170 Hikma Pharmaceuticals plc Annual Report 2016 171
